Results 51 to 60 of about 26,464 (219)

Susceptibility of soybean looper to lufenuron and spinosad

open access: yesArquivos do Instituto Biológico
: The soybean looper (Chrysodeixis includens) is an important defoliation pest in crops such as soybean and cotton in Brazil. Its main control tactic is chemical insecticides.
Lucas Ferraz de Queiroz   +3 more
doaj   +1 more source

Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola   +4 more
wiley   +1 more source

Surgical Management of Resistant Priapism [PDF]

open access: yesIndian Journal of Surgery, 2011
We report a 31 year old patient, presented with painful erection since 48 hours. There was no known predisposing factor on history and examination. Surgery for priapism is rarely indicated nowadays but conservative management failed to achieve detumescence in our case.
Rikki, Singal   +4 more
openaire   +2 more sources

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa   +7 more
wiley   +1 more source

Anticoagulant resistance in the UK and a new guideline for the management of resistant infestations of Norway rats (Rattus norvegicus Berk.)

open access: yesJulius-Kühn-Archiv, 2011
Anticoagulant resistance was first discovered in UK Norway rats (Rattus norvegicus Berk.) in 1958 and has been present ever since. The possible detrimental impact of resistance on effective rodent control was quickly recognised and, for almost three ...
Buckle, A.
doaj   +1 more source

Phosphine resistance in saw-toothed grain beetle, Oryzaephilus surinamensis (Coleoptera: Silvanidae) in the United States

open access: yesJulius-Kühn-Archiv, 2018
Sub-lethal dose application of phosphine (PH3) that is mostly caused by leakage during fumigation has resulted in resistance in Tribolium castaneum, Rhyzopertha dominica, Cryptolestes ferrugineus, Sitophilus oryzae, and other stored-product insect pest ...
Hubhachen, Zhaorigetu   +4 more
doaj   +1 more source

Reciprocal control of viral infection and phosphoinositide dynamics

open access: yesFEBS Letters, EarlyView.
Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley   +1 more source

Microbiome−host proteostasis crosstalk—An emerging perspective on mechanisms and interventions toward healthy longevity

open access: yesFEBS Letters, EarlyView.
Proteostasis and the gut microbiota play a key role in shaping host physiology. Microbiota‐derived metabolites, vitamins, and RNA modulate host proteostasis. Findings from model systems, including C. elegans, indicate microbes can either stabilize or disrupt host proteostasis.
Abhishek Anil Dubey, Maria Ermolaeva
wiley   +1 more source

Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses

open access: yesmBio
The rise in infections caused by multidrug-resistant (MDR) bacteria has necessitated a variety of clinical approaches, including the use of antibiotic combinations.
Kathleen P. Davis   +6 more
doaj   +1 more source

HIV therapy: Managing resistance [PDF]

open access: yesProceedings of the National Academy of Sciences, 2000
Over the last years, a number of potent drugs have been developed that inhibit HIV-1 replication in vivo . Treatment regimes involving a combination of three or more different drugs can induce a decline in virus load by several orders of magnitude, as well as a significant rise in the CD4 cell count.
D, Wodarz, M A, Nowak
openaire   +2 more sources

Home - About - Disclaimer - Privacy